Conduit Pharmaceuticals Inc. (CDT)

NASDAQ: CDT · IEX Real-Time Price · USD
1.800
-0.220 (-10.89%)
At close: Jun 14, 2024, 4:00 PM
1.830
+0.030 (1.67%)
After-hours: Jun 14, 2024, 7:54 PM EDT
-10.89%
Market Cap 132.89M
Revenue (ttm) n/a
Net Income (ttm) -2.30M
Shares Out 73.83M
EPS (ttm) -7,310.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 109,141
Open 1.910
Previous Close 2.020
Day's Range 1.590 - 2.020
52-Week Range 0.950 - 25.000
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date May 14, 2024

About CDT

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 7
Stock Exchange NASDAQ
Ticker Symbol CDT
Full Company Profile

Financial Performance

Financial Statements

News

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncolo...

Other symbols: AZN
23 days ago - Business Wire

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO.

24 days ago - Business Wire

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit also appoints prominent intellectual property attorney Jeffrey Lindeman as a Consultant Leadership additions underscore Conduit's commitment to strengthening and broadening its intellectual pr...

3 months ago - GlobeNewsWire

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory spac...

3 months ago - GlobeNewsWire

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit"), a multi-asset, clinical-stage life science company delivering an efficient model for com...

4 months ago - GlobeNewsWire

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

SAN DIEGO and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life science ...

8 months ago - GlobeNewsWire

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Collaboration underscores Conduit's mission to advance promising treatments by developing assets that have already completed Phase I trials Collaboration underscores Conduit's mission to advance promi...

8 months ago - GlobeNewsWire

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

NEW YORK--(BUSINESS WIRE)--ClinConnect, a first-of-its-kind platform redefining how patients and clinical trials find each other, today announced a partnership with Conduit Pharmaceuticals Inc. (Nasda...

8 months ago - Business Wire

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient mod...

9 months ago - GlobeNewsWire